Institutional Review Boards (IRBs) emphasize how important it is to ensure the c
ID: 176732 • Letter: I
Question
Institutional Review Boards (IRBs) emphasize how important it is to ensure the confidentiality and informed consent of the research subject/patient. Which of the following apply to CURRENT IRBs? (current in this context means existing IRBs, not the new generation of IRBs that are being developed)
A. Subjects/Patients must be identified in name, in case their samples are used for commercial gain.
B. Subjects/Patients have the right to know the outcomes of the research they are participating in.
C. Experiments must be designed to remove identifying labels from collected samples, to preserve anonymity and privacy
D. all of the above
Incidentalomas…
A. are Cancer tumors that arise at sites outside of where the original tumor(s) appeared B. are Health findings or genetic risks that are the subject of research C. are Health findings or genetic risks that are revealed outside the focus of current research D. Can be used to de-anonymize data collected using IRBsExplanation / Answer
1C Experiments must be designed to remove identifying labels from collected samples, to preserve anonymity and privacy (to protect them from embarrassment).
2. A. are cancer tumors that arise outside of where the original tumor (s) appeared
(Incidentalomas word is derived from "incidental" and "oma" means tumor, so it is a tumor found by coincidence (incidentally) without clinical symptoms